Dashboard · Pharmaceuticals stocks · SUNPHARMA
20
JayScore

Sun Pharmaceutical Industries Limited

SUNPHARMA Pharmaceuticals
High Risk Grade — 35% confidence
Score computed at ₹1,751.20 · 27 Oct 2026
Research signals 0 positive · 8 cautionary of 8
NSE
JayScore
20
vs
Sector signal
2
20
Sun Pharmaceutical Industries Limited SUNPHARMA High Risk
Get notified when this stock's JayScore changes
Free account — score alerts, daily research picks, morning plan and portfolio tracker.
Sign Up Free Sign In
About Sun Pharmaceutical Industries Limited

Sun Pharmaceutical Industries Limited is a Pharmaceuticals company listed on the National Stock Exchange (NSE) with a market capitalisation of ₹4.19 lakh crore. The company reports a net profit margin of 20.2%. Revenue grew +10.5% year-over-year. Promoter holding stands at 55.6%, with FII participation at 29.1%.

Pharmaceuticals sector signal: 2/100 — below-average — fewer than 40% of sector peers are trading above their EMA 20.
JayScore 20/100 indicates a cautionary signal — research factors show weakness across one or more key dimensions. JayScore is a quantitative index — not investment advice. Learn how it's calculated →
JaySense Research View · quantitative signals only · not investment advice
High Risk

Most stocks in the same industry are struggling (sector — most peers below EMA20). The overall market is in a downtrend — all trades carry higher risk right now (BEAR MARKET regime, reduced confidence). Above-average delivery percentage suggests real buying, not just speculation (delivery 63%).

Watch Points
Trend is weak — price may be below key averages
Fundamental score is weak relative to benchmark
Valuation appears stretched on current metrics
Sector is under pressure — headwinds may persist
Institutional activity is low or declining
Only 2 of 9 research signals are aligned
📅 Earnings on 05 Nov (9 days). Results can move price sharply — up or down. | ⚠ Low reward potential — target is less than 5% above entry after slippage. Not suitable for short-term swing entry.
Research Score Insight

Sun Pharmaceutical Industries Limited scores 20/100 (Weak Research Signal). The strongest signals are Momentum (8/100) and Growth (5/100). The weakest dimension is Institutional Activity (1/100), which warrants monitoring. This reflects JaySense quantitative research scoring only — not investment advice. Consult a SEBI Registered Investment Adviser before making any investment decision.

Trend 3 Momentum 8 Volume 3 Fundamental 1 Valuation 1 Growth 5 Institutional 1 Sector 2 Risk 3
Research Intelligence Free Account Required
0 positive · 9 risk signals identified 2 / 9 signals converging
Downtrend active — price has broken below key moving averages
Institutional indicators suggest active accumulation in this price zone
Volatility ratio and momentum signal caution at current levels
Institutional indicators suggest active accumulation in this price zone
Volatility ratio and momentum signal caution at current levels

8 more research signals — available free with a JaySense account

Get Free Access Sign in
Sector & Institutional Activity Free Account Required
Sector Health
2.4000/100
Sector Rank
#3 of 12
FII Activity
Net Buying
FII net buyers ₹840 Cr over last 10 sessions — institutional accumulation in progress
DII activity supportive — domestic funds adding to position

Sector peer rank, FII/DII trend & institutional activity — free with a JaySense account

Get Free Access Sign in
Score Analysis
Trend
3
Weak
Price vs moving averages · trend structure
Momentum
8
Weak
MACD · RSI · rate-of-change
Volume
3
Weak
Volume strength · accumulation vs distribution
Fundamental
1
Weak
Margins · returns · debt ratios
Valuation
1
Weak
PE · PB · multiples vs sector
Growth
5
Weak
Revenue & profit growth YoY
Sector
2
Weak
Sector relative strength vs market
Risk
3
Weak
Volatility · beta · drawdown risk
Institutional
1
Weak
FII / DII participation & block deals
Signal convergence: 2 / 9 dimensions aligned · Low convergence
Score Trend (Last 30 Scores)
Fundamentals
Market Cap
₹4.19 L Cr
P/E Ratio
34.68
P/B Ratio
5.02
EPS (TTM)
50.4
ROE
—
ROCE
—
Net Profit Margin
20.2%
Debt / Equity
5.52
Revenue Growth YoY
10.5%
Profit Growth YoY
27.4%
Promoter Holding
55.6%
FII Holding
29.1%
Dividend Yield
0.9%
Company Profile
Sun Pharmaceutical Industries Limited is a Pharmaceuticals company listed on the National Stock Exchange (NSE) with a market capitalisation of ₹4.19 lakh crore. The company reports a net profit margin of 20.2%. Revenue grew +10.5% year-over-year. Promoter holding stands at 55.6%, with FII participation at 29.1%.
Corporate Actions
Corporate Actions Source: NSE
Recent History
₹5.00 / share
07 Jul 2026
Dividend
How JaySense scores stocks Full stock screener
Disclaimer: JaySense scores are research outputs based on technical and fundamental signals. They are not buy/sell recommendations and do not constitute investment advice. Past score performance does not guarantee future returns. Please do your own research or consult a SEBI-registered investment advisor before making any investment decision. JaySense is not SEBI-registered. Use this platform for educational and research purposes only.